Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Changes in the cytokine profile in first-episode, drug-naïve patients with psychosis after short-term antipsychotic treatment.

Petrikis P, Voulgari PV, Tzallas AT, Boumba VA, Archimandriti DT, Zambetas D, Papadopoulos I, Tsoulos I, Skapinakis P, Mavreas V.

Psychiatry Res. 2017 Oct;256:378-383. doi: 10.1016/j.psychres.2017.07.002. Epub 2017 Jul 3.

PMID:
28688350
2.

Cytokine profile in drug-naïve, first episode patients with psychosis.

Petrikis P, Voulgari PV, Tzallas AT, Archimandriti DT, Skapinakis P, Mavreas V.

J Psychosom Res. 2015 Oct;79(4):324-7. doi: 10.1016/j.jpsychores.2015.06.011. Epub 2015 Jul 17.

PMID:
26213351
3.

[Effect of clozapine and risperidone on serum cytokine levels in patients with first-episode paranoid schizophrenia].

Lü LX, Guo SQ, Chen W, Li Q, Cheng J, Guo JH.

Di Yi Jun Yi Da Xue Xue Bao. 2004 Nov;24(11):1251-4. Chinese.

4.

Interleukin-12 plasma levels in drug-naïve patients with a first episode of psychosis: effects of antipsychotic drugs.

Crespo-Facorro B, Carrasco-Marín E, Pérez-Iglesias R, Pelayo-Terán JM, Fernandez-Prieto L, Leyva-Cobián F, Vázquez-Barquero JL.

Psychiatry Res. 2008 Mar 15;158(2):206-16. doi: 10.1016/j.psychres.2006.08.005. Epub 2008 Feb 19.

PMID:
18243335
5.

Effects of risperidone on cytokine profile in drug-naïve first-episode psychosis.

Noto C, Ota VK, Gouvea ES, Rizzo LB, Spindola LM, Honda PH, Cordeiro Q, Belangero SI, Bressan RA, Gadelha A, Maes M, Brietzke E.

Int J Neuropsychopharmacol. 2014 Oct 31;18(4). pii: pyu042. doi: 10.1093/ijnp/pyu042.

6.

Antipsychotic treatment reduces psychotic symptoms and markers of low-grade inflammation in first episode psychosis patients, but increases their body mass index.

Haring L, Koido K, Vasar V, Leping V, Zilmer K, Zilmer M, Vasar E.

Schizophr Res. 2015 Dec;169(1-3):22-29. doi: 10.1016/j.schres.2015.08.027. Epub 2015 Sep 11.

PMID:
26364730
7.

Profiling of Acylcarnitines in First Episode Psychosis before and after Antipsychotic Treatment.

Kriisa K, Leppik L, Balõtšev R, Ottas A, Soomets U, Koido K, Volke V, Innos J, Haring L, Vasar E, Zilmer M.

J Proteome Res. 2017 Oct 6;16(10):3558-3566. doi: 10.1021/acs.jproteome.7b00279. Epub 2017 Aug 24.

PMID:
28786289
8.
9.

Depression, Cytokine, and Cytokine by Treatment Interactions Modulate Gene Expression in Antipsychotic Naïve First Episode Psychosis.

Noto C, Ota VK, Santoro ML, Gouvea ES, Silva PN, Spindola LM, Cordeiro Q, Bressan RA, Gadelha A, Brietzke E, Belangero SI, Maes M.

Mol Neurobiol. 2016 Oct;53(8):5701-9. doi: 10.1007/s12035-015-9489-3. Epub 2015 Oct 22.

PMID:
26491028
10.

Superoxide dismutase and cytokines in chronic patients with schizophrenia: association with psychopathology and response to antipsychotics.

Zhang XY, Zhou DF, Qi LY, Chen S, Cao LY, Chen DC, Xiu MH, Wang F, Wu GY, Lu L, Kosten TA, Kosten TR.

Psychopharmacology (Berl). 2009 May;204(1):177-84. doi: 10.1007/s00213-008-1447-6. Epub 2009 Jan 13.

PMID:
19139851
11.

Antipsychotics can modulate the cytokine profile in schizophrenia: attenuation of the type-2 inflammatory response.

Borovcanin M, Jovanovic I, Radosavljevic G, Djukic Dejanovic S, Stefanovic V, Arsenijevic N, Lukic ML.

Schizophr Res. 2013 Jun;147(1):103-109. doi: 10.1016/j.schres.2013.03.027. Epub 2013 Apr 16.

PMID:
23602340
12.

Increase in brain-derived neurotrophic factor in first episode psychotic patients after treatment with atypical antipsychotics.

González-Pinto A, Mosquera F, Palomino A, Alberich S, Gutiérrez A, Haidar K, Vega P, Barbeito S, Ortiz A, Matute C.

Int Clin Psychopharmacol. 2010 Jul;25(4):241-5.

PMID:
20568658
13.
14.

Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis.

Upthegrove R, Manzanares-Teson N, Barnes NM.

Schizophr Res. 2014 May;155(1-3):101-8. doi: 10.1016/j.schres.2014.03.005. Epub 2014 Apr 4. Review.

PMID:
24704219
15.

Altered serum levels of interleukin-3 in first-episode drug-naive and chronic medicated schizophrenia.

Fu YY, Zhang T, Xiu MH, Tang W, Han M, Yun LT, Chen DC, Chen S, Tan SP, Soares JC, Tang WJ, Zhang XY.

Schizophr Res. 2016 Oct;176(2-3):196-200. doi: 10.1016/j.schres.2016.05.010. Epub 2016 May 26.

PMID:
27237600
16.

Effects of eight weeks of atypical antipsychotic treatment on middle frontal thickness in drug-naïve first-episode psychosis patients.

Goghari VM, Smith GN, Honer WG, Kopala LC, Thornton AE, Su W, Macewan GW, Lang DJ.

Schizophr Res. 2013 Sep;149(1-3):149-55. doi: 10.1016/j.schres.2013.06.025. Epub 2013 Jul 4.

PMID:
23830856
17.

Elevated serum level of type-2 cytokine and low IL-17 in first episode psychosis and schizophrenia in relapse.

Borovcanin M, Jovanovic I, Radosavljevic G, Djukic Dejanovic S, Bankovic D, Arsenijevic N, Lukic ML.

J Psychiatr Res. 2012 Nov;46(11):1421-6. doi: 10.1016/j.jpsychires.2012.08.016. Epub 2012 Sep 10.

PMID:
22974591
18.

Glutamate levels in the associative striatum before and after 4 weeks of antipsychotic treatment in first-episode psychosis: a longitudinal proton magnetic resonance spectroscopy study.

de la Fuente-Sandoval C, León-Ortiz P, Azcárraga M, Stephano S, Favila R, Díaz-Galvis L, Alvarado-Alanis P, Ramírez-Bermúdez J, Graff-Guerrero A.

JAMA Psychiatry. 2013 Oct;70(10):1057-66. doi: 10.1001/jamapsychiatry.2013.289.

19.

Early intervention with second-generation antipsychotics in first-episode psychosis: results of an 8-week naturalistic study.

Josiassen RC, Shaughnessy RA, Filymer DM, Donohue AM, Kacso M, Finkel N, Curtis J, Audino B, Skuban N.

Early Interv Psychiatry. 2010 Feb;4(1):57-63. doi: 10.1111/j.1751-7893.2010.00163.x.

PMID:
20199481
20.

Trajectories of symptom dimensions in short-term response to antipsychotic treatment in patients with a first episode of non-affective psychosis.

Pelayo-Terán JM, Diaz FJ, Pérez-Iglesias R, Suárez-Pinilla P, Tabarés-Seisdedos R, de León J, Crespo-Facorro B.

Psychol Med. 2014 Jan;44(1):37-50. doi: 10.1017/S0033291713000330. Epub 2013 Mar 6.

PMID:
23461899

Supplemental Content

Support Center